Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.480.02%
QQQ
714.89-
BTC/USD
77245.720.049%
DIA
525.910.02%
GLD
398.290.12%
TLT
80.930.07%

Assembly Biosciences Inc (ASMB) Stock Price, Quote, News & History

ASMBNASDAQ
Trade with Public
Trade with Public
$29.80
-0.66-2.17%
At close: Sep 11, 5:00 PM EST
$29.80
N/A
After Hours: Sep 11, 4:07 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Assembly Biosciences (ASMB) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$30.83
Close
$29.80
Volume / Avg.
258.95K / 249.76K
Day Range
$29.68 - $31.72
52 Wk Range
20.23 - 39.71
Market Cap
$606.75M
P/E Ratio
24.56
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
13.86%
Days to Cover
6.75

Recent Assembly Biosciences Inc News

Crude Oil Edges Higher; US Consumer Sentiment Falls In May

US stocks rose, Dow gained over 400 points. S&P 500 and NASDAQ also up. Health care shares jumped, while communication services fell. University of Michigan's consumer sentiment index hit record low. Oil up, gold and silver down. European and Asian markets closed higher.
Avi Kapoor

Zoom Upbeat Q1 Results, Joins Lionsgate Studios, Ross Stores And Other Big Stocks Moving Higher On Friday

Zoom Communications Inc shares rise after strong financial results and increased buyback authorization. Other big gainers include IMRX, INFQ, ASMB, IMAX, RGTI, HLIT, DELL, EL, GSIT, ELVR, and HPQ.
Avi Kapoor

Scholastic Posts Upbeat Q3 Earnings, Joins Firefly Aerospace, Arm Holdings And Other Big Stocks Moving Higher On Friday

Scholastic Corp (NASDAQ: SCHL) rose 10.7% on Friday after reporting better-than-expected earnings and announcing a $200 million buyback. Other big gainers include Planet Labs PBC (NYSE: PL), Satellogic Inc (NASDAQ: SATL), and Blacksky Technology Inc (NYSE: BKSY).
Avi Kapoor

Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes

Gilead licensed Assembly Bio's long-acting HSV drugs after Phase 1b data showed antiviral activity and weekly oral dosing potential.
Vandana Singh

4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week technical strength and strong price action.
Rishabh Mishra
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-38.48M
Investing Cash Flow (TTM)
-234.51M
Financing Cash Flow (TTM)
281.27M
Free Cash Flow (TTM)
-38.57M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
8.28M

Analyst Trends and Forecast

2
May
1
Jun
1
Aug
2
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$288.73M
PE Ratio (TTM)
24.56
PE Ratio (FWD)
625.00
PEG Ratio (TTM)
-
PS Ratio (TTM)
6.66
PB Ratio (TTM)
2.03
Earnings Yield % (TTM)
4.07%
Earnings Yield % (FWD)
0.16%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$15.01

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$32.29M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$30.83
Close
$29.80
Volume / Avg.
258.95K / 249.76K
Day Range
$29.68 - $31.72
52 Wk Range
20.23 - 39.71
Market Cap
$606.75M
P/E Ratio
24.56
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
13.86%
Days to Cover
6.75

About

Sector
Health Care
Industry
Biotechnology
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent gen...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Assembly Biosciences (ASMB) stock?

A

You can purchase shares of Assembly Biosciences (NASDAQ:ASMB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Assembly Biosciences (ASMB) competitors?

Q

What is the forecast, or price target, for Assembly Biosciences (ASMB) stock?

A

Assembly Biosciences has a consensus price target of $44.71.

Q

What is the current price for Assembly Biosciences (ASMB)?

A

The stock price for Assembly Biosciences (NASDAQ: ASMB) is $29.8 last updated September 11, 2026 at 4:07 PM EDT.

Q

Does Assembly Biosciences (ASMB) pay a dividend?

A

There are no upcoming dividends for Assembly Biosciences.

Q

When is Assembly Biosciences (NASDAQ:ASMB) reporting earnings?

A

Assembly Biosciences does not have any upcoming earnings scheduled.

Q

Is Assembly Biosciences (ASMB) going to split?

A

There is no upcoming split for Assembly Biosciences.

Q

What sector and industry does Assembly Biosciences (ASMB) operate in?

A

Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved